KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Work In Process: 2010-2018

Historic Work In Process for Idexx Laboratories (IDXX) over the last 7 years, with Mar 2018 value amounting to $18.3 million.

  • Idexx Laboratories' Work In Process fell 2.94% to $18.3 million in Q1 2018 from the same period last year, while for Mar 2018 it was $18.3 million, marking a year-over-year decrease of 2.94%. This contributed to the annual value of $17.8 million for FY2017, which is 18.59% up from last year.
  • Per Idexx Laboratories' latest filing, its Work In Process stood at $18.3 million for Q1 2018, which was up 2.62% from $17.8 million recorded in Q4 2017.
  • Over the past 5 years, Idexx Laboratories' Work In Process peaked at $20.3 million during Q2 2015, and registered a low of $14.9 million during Q2 2014.
  • Moreover, its 3-year median value for Work In Process was $18.2 million (2017), whereas its average is $17.6 million.
  • As far as peak fluctuations go, Idexx Laboratories' Work In Process skyrocketed by 35.86% in 2015, and later fell by 21.32% in 2016.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Work In Process stood at $16.9 million in 2014, then rose by 10.91% to $18.7 million in 2015, then declined by 19.79% to $15.0 million in 2016, then grew by 18.59% to $17.8 million in 2017, then declined by 2.94% to $18.3 million in 2018.
  • Its last three reported values are $18.3 million in Q1 2018, $17.8 million for Q4 2017, and $18.2 million during Q3 2017.